Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey

Palliative Medicine

Volumn 18, Issue 3, 2004, Pages 177-183

  Caraceni, Augusto ^a   Martini, Cinzia ^a   Zecca, Ernesto ^a   Portenoy, Russell K ^b   Ashby, M A ^c   Hawson, G ^c   Jackson, K A ^c   Lickiss, N ^c   Muirden, N ^c   Pisasale, M ^c   Moulin, D ^c   Schulz, V N ^c   Pazo, M A Rico ^c   Serrano, J A ^c   Andersen, H ^c   Henriksen, H T ^c   Meljholm, I ^c   Sjogren, P ^c   Heiskanen, T ^c   Kalso, E ^c   Pere, P ^c   Poyhia, R ^c   Vuorinen, E ^c   Tigerstedt, I ^c   Ruismaki, P ^c   Bertolino, M ^c   Larue, F ^c   Ranchere, J Y ^c   Hege Scheuing, G ^c   Bowdler, I ^c   Helbing, F ^c   Kostner, E ^c   Radbruch, L ^c   Kastrinaki, K ^c   Shah, S ^c   Vijayaram, S ^c   Sharma, K S ^c   Sarashawathi Devi, P ^c   Jain, P N ^c   Ramamani, P V ^c   Beny, A ^c   Brunelli, C ^c   Maltoni, M ^c   Mercadante, S ^c   Plancarte, R ^c   Schug, S ^c   Engstrand, P ^c   Ovalle, A F ^c   Wang, X ^c   Ferraz Alves, M ^c   Abrunhosa, M R ^c   Sun, W Z ^c   Zhang, L ^c   Gazizov, A ^c   Vaisman, M ^c   Rudoy, S ^c   Gomez Sancho, M ^c   Vila, P ^c   Trelis, J ^c   Chaudakshetrin, P ^c   Koh, M L J ^c   Van Dongen, R T M ^c   Vielvoye Kerkmeer, A ^c   Boswell, M V ^c   Elliott, T ^c   Hargus, E ^c   Lutz, L ^c   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c NONE

Author keywords

Breakthrough pain; Cancer pain; Cancer pain classification; Cancer pain syndromes; IASP Task Force on Cancer Pain

Indexed keywords

ADULT; BREAKTHROUGH PAIN; CANCER PAIN; CANCER PATIENT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; FUNCTIONAL DISEASE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SPINAL PAIN;

ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN MEASUREMENT; PREVALENCE; SYNDROME;

EID: 2942637938     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216304pm890oa     Document Type: Review

References (28)

1. Mercadante S, Radbruch L, Caraceni A, et al. Episodic (breakthrough) pain. Consensus conference of an expert working group of the European Association for Palliative Care. Cancer 2002; 94: 832-39.
2. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41: 273-81.
3. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-34.
4. Zeppetella G, O'Doherty C, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Sympt Manage 2000; 20: 87-92.
5. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003; 101: 55-64.
6. Banning A, Sjogren P, Henriksen H. Treatment outcome in a multidisciplinary cancer pain clinic. Pain 1991; 47: 129-34.
7. Bruera E, MacMillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: preliminary report. Pain 1989; 37: 203-209.
8. Mercadante S, Maddaloni S, Roccella S, Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain 1992; 50: 151-55.
9. Farrar JT, Cleary J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of break-through pain in cancer patients. J Natl Cancer Inst 1998; 90: 661-66.
10. Christie JM, Simmonds M, Patt R, et al. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 1998; 16: 3238-45.
11. Portenoy RK, Payne R, Coluzzi P, et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 1999; 79: 303-12.
12. Zeppetella G. An assessment of the safety, efficacy and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Sympt Manage 2000; 20: 253-58.
13. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001; 91: 123-30.
14. Enting RH, Oldenmenger WH, van der Rijt C, Koper P, Lieverse PJ, Sillevits Smitt PAE. Nitrous oxide is not beneficial for breakthrough cancer pain. Palliat Med 2002; 16: 257-59.
15. Caraceni A, Portenoy RK, a working group of the IASP task force on cancer pain. An international survey of cancer pain characteristics and syndromes. Pain 1999; 82: 263-74.
16. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In MacLeod ed. Evaluation of chemotherapeutic agents. New York, NY: Columbia University Press, 1949: 199-205.
17. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277-84.
18. Merksey H, Bogduk N. Classification of chronic pain, second edition. Seattle, WA: IASPP Press, 1994.
19. Grond S, Zech D, Diefenbach C, Radbruch L, Lehman KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996; 64: 107-14.
20. Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage 1998; 16: 179-83.
21. Gomez-batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. J Pain Sympt Manage 2002; 24: 45-52.
22. Swanwick M, Haworth M, Lennard R. The prevalence of episodic pain in cancer: a survey of hospice patients on admission. Palliat Med 2001; 15: 9-18.
23. Petzke F, Radbruch L, Zech D, Loick G, Grond S. Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Sympt Manage 1999; 17: 391-401.
24. Greenwald HP. Interethnic differences in pain perception. Pain 1991; 44: 157-63.
25. Hess PE, Pratt SD, Lucas TP, et al. Predictors of breakthrough pain during labor epidural analgesia. Anesth Analg 2001; 93: 414-18.
26. Portenoy RK. Treatment of temporal variations in chronic cancer pain. Semin Oncol 1997; 24: 7-12.
27. Mercadante S. What is the definition of breakthrough pain? Pain 1991; 45: 107.
28. Hanks GWC, Portenoy RK, MacDonald N, Forbes K. Difficult pain problems. In Doyle D, Hanks GW, MacDonald N eds. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998: 454-87.